Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity. - Wikidata - wikimedia - TriplyDB

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

http://www.wikidata.org/entity/Q35208414

about

NK Cells, Tumor Cell Transition, and Tumor Progression in Solid Malignancies: New Hints for NK-Based Immunotherapy?Natural Killer Cell Immunomodulation: Targeting Activating, Inhibitory, and Co-stimulatory Receptor Signaling for Cancer Immunotherapy The Application of Natural Killer Cell Immunotherapy for the Treatment of Cancer Newtonian cell interactions shape natural killer cell education NK Cell Inflammation in the Clinical Outcome of Colorectal Carcinoma NK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma NKG2D ligands as therapeutic targets From mice to humans: developments in cancer immunoediting The receptors CD96 and CD226 oppose each other in the regulation of natural killer cell functions Altered expression of miR-181a and miR-146a does not change the expression of surface NCRs in human NK cells.Cytotoxicity and infiltration of human NK cells in in vivo-like tumor spheroids.DNAM-1 control of natural killer cells functions through nectin and nectin-like proteins.NKG2D+CD4+ T Cells Kill Regulatory T Cells in a NKG2D-NKG2D Ligand- Dependent Manner in Systemic Lupus Erythematosus.Reversal of NK-cell exhaustion in advanced melanoma by Tim-3 blockade.On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C Ex vivo expanded natural killer cells from breast cancer patients and healthy donors are highly cytotoxic against breast cancer cell lines and patient-derived tumours.New insights into the role of EMT in tumor immune escape.mTORC1-dependent metabolic reprogramming is a prerequisite for NK cell effector function.Balancing natural killer cell activation through paired receptors.CD11b(-)CD27(-) NK cells are associated with the progression of lung carcinoma.NK cells and T cells cooperate during the clinical course of colorectal cancer.Tertiary Lymphoid Structure-Associated B Cells are Key Players in Anti-Tumor Immunity.A think tank of TINK/TANKs: tumor-infiltrating/tumor-associated natural killer cells in tumor progression and angiogenesis.Cytokines reinstate NK cell-mediated cancer immunosurveillance.Inherent transcriptional signatures of NK cells are associated with response to IFNα + rivabirin therapy in patients with Hepatitis C Virus Blockade of MMP14 activity in murine breast carcinomas: implications for macrophages, vessels, and radiotherapy.Overexpression of IL-15 promotes tumor destruction via NK1.1+ cells in a spontaneous breast cancer model.CTLA-4⁺ Regulatory T Cells Increased in Cetuximab-Treated Head and Neck Cancer Patients Suppress NK Cell Cytotoxicity and Correlate with Poor Prognosis.Adipose cells promote resistance of breast cancer cells to trastuzumab-mediated antibody-dependent cellular cytotoxicity.Victory and defeat in the induction of a therapeutic response through vaccine therapy for human and canine brain tumors: a review of the state of the art.Coordinated Activation of Toll-Like Receptor8 (TLR8) and NLRP3 by the TLR8 Agonist, VTX-2337, Ignites Tumoricidal Natural Killer Cell Activity Ionomycin Treatment Renders NK Cells Hyporesponsive.Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer.Tumor microenvironment in NSCLC suppresses NK cells function.Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells.Potential Use of Natural Killer Cell Transfer Therapy in the Perioperative Period to Improve Oncologic Outcomes.Increased NK Cell Maturation in Patients with Acute Myeloid Leukemia Biological role of NK cells and immunotherapeutic approaches in breast cancer.Natural killer cells in non-hematopoietic malignancies Lung tumor microenvironment induces specific gene expression signature in intratumoral NK cells.

P2860

Q26746478-E9005528-202F-4F7B-95F4-C2108F622CC7 Q26772347-7B63A60F-8561-45AE-8B82-FE53830957D3 Q26774678-6968BB9F-4FED-4F24-9A2A-B20BED6DACD2 Q26797240-AA51F512-1773-4922-AF8D-5CCB5A9DD4C0 Q26991949-B5E66F09-DDAD-4414-A099-5F72ECEADA9F Q27001052-45C0F1F3-E2F6-4F09-B14C-8AF864AFE632 Q27014888-7B8BF14D-8D22-4A3A-945B-C2770A82D0D8 Q28088304-DB7A4BF5-6198-4A9C-8881-3ACF1963A4C7 Q28589215-69F75F29-3100-4223-818D-8BBD7FB81E0B Q30364263-627D0EBA-4E1E-499C-B0FE-FA273DF6F578 Q30648415-CEBDFF24-F023-4C4D-BBA4-61F0B376CFAC Q30716850-0E96A64E-4C95-421E-9A89-59C298369B62 Q33682274-48535626-37A8-48C0-AC73-16959954AED5 Q33714165-B3FCF9A0-D74C-49AA-885E-771BF3D92921 Q33803540-3156D289-04AF-4B35-84B2-F85D3E234AFC Q33861833-AC0AD1B3-0F6A-4995-BB99-5D77BD9E90EC Q33869781-586B931D-D68C-4747-B6F7-AAAC2A724BFB Q34364808-F5FF7366-C518-42B4-907E-19BFC6C1D57A Q34465877-B845CB40-9A73-45B8-9CFE-F185085C6205 Q34658702-DB838E04-DF43-49ED-BC63-9286AE0374B7 Q34933101-30B3407B-D90F-4D30-8C29-C80DF7E05A90 Q35110486-8D43BE90-23EB-4344-8A1E-270DC4D33C28 Q35131244-EC43EDF5-4B24-4D1F-BE4E-1B4938DAF6CF Q35140082-68B25626-8B90-48F2-9FBB-AD994974CE0A Q35158581-615D55DF-530A-44F9-ACAB-730CBDF04CE6 Q35474102-346F5354-CBD5-4435-8180-C858036E0F14 Q35595605-E518819D-CA0D-4702-BBB5-398C46F716F8 Q35674757-98161875-31B9-4D2F-8752-E59BC8D9BA87 Q35786749-F8411135-42FC-4D60-9305-472CEA37B2A8 Q35799695-EFEFDFBE-34C7-4C02-9F1E-F81BE6B1037B Q35940189-C49E7EF9-B498-49CF-8C34-D22959EDAE70 Q35967256-3AD008D2-1EC0-4737-AE92-C47ABBBBF974 Q35987354-81F01398-817F-4864-97C9-7B2A4457915B Q36038484-544484BF-A99C-4A70-85E9-E861F7D0E4D5 Q36057599-3999E939-6180-407F-BED2-87588A0796D3 Q36245682-694F9F3B-D022-42E7-B063-DF734DD48C4D Q36256263-A6FFE1FB-D8C9-4CBF-86EE-FBBD6915147C Q36460884-C510F601-09C8-4422-8E5E-79F11FC77DF1 Q36486204-21E3671A-C526-4045-85D8-DADCEC831C5A Q36584068-1435E454-AAF6-4B02-8973-6D462C0BE7C1

P2860

Human breast cancer cells enhance self tolerance by promoting evasion from NK cell antitumor immunity.

http://www.wikidata.org/entity/Q35208414

description

2011 nî lūn-bûn

@nan

2011 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Human breast cancer cells enha ...... om NK cell antitumor immunity.

@ast

Human breast cancer cells enha ...... om NK cell antitumor immunity.

@en

type

label

Human breast cancer cells enha ...... om NK cell antitumor immunity.

@ast

Human breast cancer cells enha ...... om NK cell antitumor immunity.

@en

prefLabel

Human breast cancer cells enha ...... om NK cell antitumor immunity.

@ast

Human breast cancer cells enha ...... om NK cell antitumor immunity.

@en

P1433

Q35208414-17941CC2-9448-42D7-88EF-76A3DFB8C478

P1476

Q35208414-A80E8ABC-92EA-49FA-8070-9EB80F2C645D

P2093

Q35208414-0389491F-05BE-43B4-82E9-D368BEEBC6E8

Q35208414-0B0BE8A9-DEE6-49DA-BBC5-B8747B9AD2A4

Q35208414-1D8D1870-9271-443C-B921-56E4A15E059C

Q35208414-26B30816-B5DC-4F05-8C29-9D20B6FF9D9B

Q35208414-45986BF4-CC65-4D41-9DBD-CC03D75B7DC7

Q35208414-48E27E94-649E-445F-82BE-FDD9C211AAFB

Q35208414-5A494F2D-DFDB-487A-894A-C1F1A26C5671

Q35208414-6CEB3322-5812-4304-A7A6-3D0569A6053F

Q35208414-7D63BC01-22AE-4C1E-8278-0DC3193B1CFA

Q35208414-AA97E52D-B148-4749-BD7E-50967B95631E

P2860

Q35208414-003D4DEF-BA54-4DCB-8877-210DA6D10228

Q35208414-018332AD-A79D-4CEA-BFFD-E0119A12883A

Q35208414-01A793C7-AB92-4C28-BF20-CF971B3EF66B

Q35208414-07372E76-9A2E-4A58-82BD-46C5FF6970E4

Q35208414-0A7AE25A-57DA-4A33-8147-030F4481B2C9

Q35208414-0D2CFD3E-48C3-42FA-957C-3AEA0D92C38D

Q35208414-0E0A2E3A-DEF7-48DC-97DD-310D5558057E

Q35208414-141CEEE8-60B2-4441-857D-361D5F86067C

Q35208414-1B11AC77-78ED-4F2C-989C-58513BCF4125

Q35208414-1C44755A-CEDA-4B60-B6BF-8470761681A2

P304

Q35208414-E0F62883-E0E1-4151-A5C5-70C034CBC3AC

P31

Q35208414-36BDDA12-3F51-4EE6-B3EE-C33A71AED3C1

P356

Q35208414-9BB9C426-E857-49CE-B2B5-EED3CFA6FFB3

P407

Q35208414-711C35FB-7332-45B5-AB7C-7B7C57ECF053

P433

Q35208414-5D0FC473-C555-4CEE-B8E7-DDF4F85905A4

P478

Q35208414-4030661A-1E3B-498E-B1FB-3FA15323BD4A

P50

Q35208414-6EC395C6-14FD-4D1A-9192-60CE822EA213

Q35208414-88087475-3826-4FFD-96B7-A043F8D224BD

Q35208414-C71074E9-28B3-48A4-AFE7-67975395F3E8

Q35208414-F9E11A29-8D38-4012-AADF-A2130AA2BF5B

P577

Q35208414-A844EB07-9402-43BE-92F4-47C52C14DEC0

P698

Q35208414-52BCA3C1-D0E9-4C27-9392-B29FF577A818

P932

Q35208414-211CCA47-6374-42AB-9ECF-CED444450085

P356

P1433

Journal of Clinical Investigation

P1476

Human breast cancer cells enha ...... om NK cell antitumor immunity.

@en

P2093

Alessandro Moretta

http://www.w3.org/2001/XMLSchema#string

Anthony Gonçalves

http://www.w3.org/2001/XMLSchema#string

Aude Sylvain

http://www.w3.org/2001/XMLSchema#string

Daniel Birnbaum

http://www.w3.org/2001/XMLSchema#string

Daniel Olive

http://www.w3.org/2001/XMLSchema#string

Emilie Mamessier

http://www.w3.org/2001/XMLSchema#string

François Bertucci

http://www.w3.org/2001/XMLSchema#string

François Romagné

http://www.w3.org/2001/XMLSchema#string

Gilles Thibault

http://www.w3.org/2001/XMLSchema#string

Marie-Laure Thibult

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of NK cells and T cells by NKG2D, a receptor for stress-inducible MICA

Immune-induced epithelial to mesenchymal transition in vivo generates breast cancer stem cells

Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: consequences for the NK-mediated killing of dendritic cells

The use of molecular profiling to predict survival after chemotherapy for diffuse large-B-cell lymphoma.

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

Opinion: migrating cancer stem cells - an integrated concept of malignant tumour progression

Epithelial-mesenchymal transition: at the crossroads of development and tumor metastasis

Expression of the neu protooncogene in the mammary epithelium of transgenic mice induces metastatic disease.

Complex networks orchestrate epithelial-mesenchymal transitions

Microenvironmental regulation of metastasis

P304

3609-3622

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1172/JCI45816

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

121

http://www.w3.org/2001/XMLSchema#string

P50

Gilles Houvenaeghel

Emilie Mamessier

Jocelyne Jacquemier

Marie-Laure Thibult

P577

2011-08-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

21841316

http://www.w3.org/2001/XMLSchema#string

P932

3171102

http://www.w3.org/2001/XMLSchema#string